{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:45:20Z","timestamp":1761518720029,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8419","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003248","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AGNS 03047"],"award-info":[{"award-number":["AGNS 03047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council Canada","doi-asserted-by":"publisher","award":["PG21"],"award-info":[{"award-number":["PG21"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1016\/s0140-6736(85)90966-3","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T07:00:29Z","timestamp":1065855629000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES"],"prefix":"10.1016","volume":"325","author":[{"given":"Carsten","family":"Rose","sequence":"first","affiliation":[]},{"given":"KnudW.","family":"Andersen","sequence":"additional","affiliation":[]},{"given":"HenningT.","family":"Mouridsen","sequence":"additional","affiliation":[]},{"given":"SusanM.","family":"Thorpe","sequence":"additional","affiliation":[]},{"given":"BoV.","family":"Pedersen","sequence":"additional","affiliation":[]},{"given":"Mogens","family":"Blichert-Toft","sequence":"additional","affiliation":[]},{"given":"BirgitteB.","family":"Rasmussen","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(85)90966-3_BIB1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/978-3-642-82188-2_33","article-title":"Treatment of advanced breast cancer with tamoxifen","volume":"91","author":"Rose","year":"1984","journal-title":"Rec Results Cancer Res"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB2","first-page":"134","article-title":"Therapeutic effect of tamoxifen related to estrogen receptor level","volume":"71","author":"Rose","year":"1980","journal-title":"Rec Results Cancer Res"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(81)91341-6","article-title":"Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy","volume":"ii","author":"Campbell","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01806237","article-title":"Antiestrogen treatment of postmenopausal women with primary high risk breast cancer 36 months of life-table analysis and steriod hormone receptor status","volume":"3","author":"Rose","year":"1983","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB5","first-page":"257","article-title":"Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer","volume":"i","author":"Baum","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB6","first-page":"379","article-title":"Adjuvant endocrine therapy","volume":"24","author":"Palshof","year":"1981","journal-title":"Can J Surg"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB7","unstructured":"A. Wallgren, E. Baral, J. Carstensen, et al., Should adjuvant tamoxifen be given for several years in breast cancer? In: Se Jones, Se Salmon (Eds), Adjuvant therapy of cancer IV., Grune & Stratton, New York ((in press))."},{"key":"10.1016\/S0140-6736(85)90966-3_BIB8","first-page":"1256","article-title":"Randomised trial of chemoendocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis","volume":"i","author":"Breast","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.286.6368.827","article-title":"Adjuvant tamoxifen for operable carcinoma of the breast: Report of clinical trial by the Christie Hospital and Holt Radium Institute","volume":"286","author":"Ribeiro","year":"1983","journal-title":"Br Med J"},{"year":"1982","series-title":"Adjuvant tamoxifen treatment in operable breast cancer. Scandinavian Breast Cancer Symposium in \u00c5arhus, Denmark","author":"Wallgren","key":"10.1016\/S0140-6736(85)90966-3_BIB10"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB11","first-page":"102","article-title":"Organization of the Danish adjuvant trials in breast cancer","volume":"28","author":"Andersen","year":"1981","journal-title":"Dan Med Bull"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/bjc.1957.43","article-title":"Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years","volume":"11","author":"Bloom","year":"1957","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB13","first-page":"1513","article-title":"Revision of standards for the assessment of hormone receptor in human breast cancer Report of the Second EORTC Workshop","volume":"16","author":"Eortc","year":"1980","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0277-5379(83)90199-2","article-title":"Standardization of steroid receptor assays in human breast cancer-I. Reproducibility of estradiol and progesterone receptor assays","volume":"19","author":"Koenders","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Stat Sec B"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB16","first-page":"82","article-title":"Hormonal control of growth and progression in tumors of Nb rats and a theory of action","volume":"37","author":"Noble","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1983.1.4.227","article-title":"Influence oftumour estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer","volume":"1","author":"Fisher","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01855129","article-title":"Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results","volume":"3","author":"Pearson","year":"1983","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(79)92752-1","article-title":"Oestrogen receptors and prognosis in early breast cancer","volume":"i","author":"Cooke","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/bjc.1981.205","article-title":"Oestrogen-receptor status and sites of metastasis in breast cancer","volume":"44","author":"Campbell","year":"1981","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(85)90966-3_BIB21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910280604","article-title":"Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patients","volume":"28","author":"Godolphin","year":"1981","journal-title":"Int J Cancer"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673685909663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673685909663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:52:35Z","timestamp":1758844355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673685909663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":21,"journal-issue":{"issue":"8419","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["S0140673685909663"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(85)90966-3","relation":{},"ISSN":["0140-6736"],"issn-type":[{"type":"print","value":"0140-6736"}],"subject":[],"published":{"date-parts":[[1985,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUES","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(85)90966-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1985 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}